Yossi Maimon
2009 - Protalix BioTherapeutics
In 2009, Yossi Maimon earned a total compensation of $640.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $253,030 |
| Salary | $186,478 |
| Other | $41,051 |
| Total | $640,559 |
Maimon received $253K in option awards, accounting for 40% of the total pay in 2009.
Maimon also received $160K in bonus, $186.5K in salary and $41.1K in other compensation.
Rankings
In 2009, Yossi Maimon's compensation ranked 5,981st out of 9,885 executives tracked by ExecPay. In other words, Maimon earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,981 out of 9,885 | 40th |
Division Manufacturing | 2,163 out of 3,690 | 41st |
Major group Chemicals And Allied Products | 464 out of 866 | 46th |
Industry group Drugs | 308 out of 638 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 57 out of 133 | 57th |
Source: SEC filing on May 21, 2012.
Maimon's colleagues
We found three more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2009.